Martinson, L, Westman, J, Hallgren, J, Osby, U, Backlund, L. Lithium treatment and cancer incidence in bipolar disorder. Bipolar Disord
2016; 18: 33–40.
Malhi, GS, Tanious, M, Das, P, Coulston, CM, Berk, M. Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs
2013; 27: 135–53.
Pottegard, A, Hallas, J, Jensen, BL, Madsen, K, Friis, S. Long-term lithium use and risk of renal and upper urinary tract cancers. J Am Soc Nephrol
2016; 27: 249–55.
Zaiden, M, Stucker, F, Stengel, B, Vasiliu, V, Hummel, A, Landais, P, et al. Increased risk of solid renal tumours in lithium-treated patients. Kidney Int
2014; 86: 184–90.
Kessing, LV, S⊘ndergård, L, Forman, JL, Andersen, PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry
2008; 65: 1331–5.
Pottegard, A, Ennis, ZN, Hallas, J, Jensen, BL, Madsen, K, Friis, S. Long-term use of lithium and risk of colorectal adenocarcinoma: a nationwide case-control study. Br J Cancer
2016; 114: 571–5.
Huang, RU, Hsieh, KP, Huang, WW, Yang, YH. Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. Br J Psychiatry
2016; 209: 393–9.
Morris, G, Berk, M. The putative use of lithium in Alzheimer's disease. Curr Alzheimer Res
2016; 13: 853–61.
Khasraw, M, Ashley, D, Wheeler, G, Berk, M. Using lithium as a neuroprotective agent in patients with cancer. BMC Med
2012; 10: 131.
Hayes, JF, Marston, L, Walters, K, Geddes, JR, King, M, Osborn, DP. Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records. World Psychiatry
2016; 15: 53–8.
Cipriani, A, Hawton, K, Stockton, S, Geddes, JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ
2013; 346: f3646.